ExploreWatchlistsPricing
  1. US-listed companies
  2. Sonnet BioTherapeutics Holdings, Inc.
  3. Financials
  4. Return on Assets

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Market cap
$1.26
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Sep 30, 2025-181.4+0.00%
Sep 30, 2024-181.4-45.78%
Sep 30, 2023-334.5+95.97%
Sep 30, 2022-170.7+26.36%
Sep 30, 2021-135.1+10.03%
Sep 30, 2020-122.8+112.39%
Dec 31, 2019-57.8+152.89%
Dec 31, 2018-22.9+7.12%
Dec 31, 2017-21.3-11.01%
Dec 31, 2016-24-22.94%
Dec 31, 2015-31.1+51.88%
Dec 31, 2014-20.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat